-
Why 4K? The latest TV tech flop?
Mitch Weinraub CommunicationsAs the "soft" announcements continue to roll out that a number of players (DirecTV, Netflix, etc.) are planning to launch 4K TV services, it probably makes sense to take a step back and ask both why and when? Of course, planning could mean anything from "we've penciled it for 2017" to "we will have a channel launched before the end of the year." That aside, why would anyone be in a rush to ready a 4K TV service?
-
The real economics behind Internet access in America
Victor Blake CommunicationsIn our competitive world, journalists and politicians have taken it upon themselves to explain, in poorly informed terms, why "broadband" is "more expensive in the U.S." Sadly, even the U.S. government has done a better job of explaining what some of the challenges are in the FCC's annual Broadband Progress Report. The cost of providing a service may involve any number of factors including competition, demand and other economic factors.
-
Technology and medicine: Applying Google Glass in the medical field
Rosemary Sparacio Medical & Allied HealthcareEvery day, new strides in technology make headlines in all kinds of areas. Nowhere is it is more prevalent or exciting than in the medical field. And one of the most talked about new tech "gadgets" to come onto the scene and into the consciousness of just about everyone who follows the news is Google Glass. The last few months have seen story after story about Goggle Glass being used by physicians.
-
Fabricated green building products rapidly advancing
Don Rosato EngineeringGreen building technology redefines how we make and live in buildings. From a plastics processing standpoint, we can both reduce a building's energy consumption and simultaneously provide for a building's energy production.
-
Making local access more accessible
Victor Blake CommunicationsIn recent years, we've seen the evolution of emergency systems to include both forward and reverse services for cellular networks and subscribers. Clearly mobile networks (when combined across all of the mobile service providers) are more geographically ubiquitous than any fixed-access network alone can be.
-
All it takes is a triple, but no new TV service has hit more than a double
Mitch Weinraub CommunicationsWe continue to see myriad new "smart TVs," OTT set-top boxes and/or services step up to the plate in the home entertainment market, but they all seem to be missing the mark. In order to reach mass-market status — in the U.S. at least — three key elements are required. Yet each new entrant to date has hit no more than a double.
-
Latest automation techniques in immunohematology testing
Dr. Afsaneh Motamed-Khorasani Medical & Allied HealthcareAutomated analyzers have been used in many clinical laboratories since their discovery in mid-1950s. They have many advantages that include improved quality of preanalytical steps, reduced error rates and reduced individual exposure to biohazardous materials. Newer techniques such as column agglutination, solid-phase red cell adherence assay and erythrocyte-magnetized technology are being adapted in immunohematology.
-
Is Mars rusted?
Sasha ViasashaThe simple answer is likely “yes,” but the most accurate answer is “no one knows.” The red hue of Mars comes from a fine layer of iron oxide that has gone through a transformation similar to rust, but in the absence of oxygen and water. What exactly that means is a matter of heated debate. We need to find the answer quickly, however, because there are at least 14 independent missions to Mars in development right now, and the closest repair shop will be 34 million miles away.
-
Targeting mitochondrial ROS: A novel therapy for a number of diseases
Dr. Afsaneh Motamed-KhorasaniReactive oxygen species are generated in a number of physiological reactions in our body. They are responsible for a number of diseases, such as cancer, inflammatory, autoimmune and neurodegenerative disorders. Currently, an effective antioxidant therapy is not available. Therefore, an in-depth knowledge of the mechanisms responsible for the production of ROS and their role in the inflammation pathways is critical for the development of new drugs.
-
Experiment reveals the ugly side of open-source journal industry
Pamela Lewis Dolan Medical & Allied HealthcareOver the past 10 months, Harvard researcher John Bohannon, Ph.D., has created more than 300 versions of a phony research paper describing the anticancer property of a chemical extracted from a lichen. Each paper was authored by a different made-up researcher who came from academic facilities that don’t exist. Despite Bohannon’s efforts to make the papers flawed and unpublishable, nearly 160 medical journal publishers accepted the paper for publishing, despite each one claiming to have a peer review process.
All Science & Technology Articles